Study probes function of Huntington's disease protein in injured neurons
In a new University at Buffalo-led study, scientists propose a new role for the huntingtin protein (HTT), which causes Huntington's disease when mutated.
Sep 27, 2022
0
7
In a new University at Buffalo-led study, scientists propose a new role for the huntingtin protein (HTT), which causes Huntington's disease when mutated.
Sep 27, 2022
0
7
Duchenne muscular dystrophy (DMD) is caused by a genetic mutation and affects one in every 5,000 boys born. Because the affected gene is on the X chromosome, girls are carriers of the mutant gene but develop the disease only ...
Sep 27, 2022
0
982
Glioblastoma, the most common cancerous brain tumor in adults, is an aggressive disease—patients survive an average of just 15 months once they are diagnosed. Despite more than two decades of research on the causes and ...
Sep 26, 2022
1
59
Placental malaria as a consequence of Plasmodium falciparum infections can lead to severe complications for both mother and child. Each year, placental malaria causes nearly 200,000 newborn deaths, mainly due to low birth ...
Sep 26, 2022
0
27
Researchers at the University of Gothenburg have been studying the mucus involved in defending the intestines and airways against infection for more than 30 years. To date, their work has focused very much on the large intestine, ...
Sep 23, 2022
0
61
A study led by researchers at the University of Arizona Health Sciences discovered new information about the inner workings of the immune system that could have a profound impact on T cell therapies for cancer and other diseases.
Sep 7, 2022
0
65
The locus coeruleus is among the first brain regions to degenerate in Alzheimer's and Parkinson's disease, physicians and scientists have known. But why this area is so vulnerable is less understood.
Sep 1, 2022
0
42
T cells used in immunotherapy treatments can get exhausted by the task of fighting cancer cells or get shutdown as they enter tumors. Using a CRISPR-based edit on these cells' genomes, researchers at UC San Francisco and ...
Aug 24, 2022
0
56
A new research paper was published in Oncotarget on August 3, 2022, entitled, "Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma."
Aug 11, 2022
0
2
The discovery of how to shift damaged brain cells from a diseased state into a healthy one presents a potential new path to treating Alzheimer's and other forms of dementia, according to a new study from researchers at UC ...
Aug 11, 2022
0
150